CD4 and immunodeficiency disease: The finding that HIV patients who started antituberculous therapy with unknown CD4 cell count had higher mortality has been described elsewhere and it suggests that patients who lacked a baseline CD4 cell count, actually, presented advanced immunodeficiency [15].